[Various aspects of humoral disorders in recent myocardial infarct and their significance in clinical practice].
D000208:Acute Disease; D000311:Adrenal Glands / Q000503:physiopathology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D002395:Catecholamines / Q000502:physiology*; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000503:physiopathology*; D011188:Potassium / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D007328:Insulin; D011943:Receptors, Adrenergic, beta; D005947:Glucose; D011188:Potassium
Niektóre aspekty zaburzeń humoralnych w świezym zawale serca i ich znaczenie dla praktyki klinicznej.